• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织和粪便的微生物群及代谢特征揭示了结直肠癌的诊断生物标志物。

Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer.

作者信息

Feng Jiahui, Gong Zhizhong, Sun Zhangran, Li Juan, Xu Na, Thorne Rick F, Zhang Xu Dong, Liu Xiaoying, Liu Gang

机构信息

School of Life Sciences, Anhui Medical University, Hefei, China.

Henan International Joint Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provincial Key Laboratory of Long Non-coding RNA and Cancer Metabolism, Translational Research Institute of Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.

出版信息

Front Microbiol. 2023 Jan 13;14:1034325. doi: 10.3389/fmicb.2023.1034325. eCollection 2023.

DOI:10.3389/fmicb.2023.1034325
PMID:36712187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9880203/
Abstract

Microbiome and their metabolites are increasingly being recognized for their role in colorectal cancer (CRC) carcinogenesis. Towards revealing new CRC biomarkers, we compared 16S rRNA gene sequencing and liquid chromatography-mass spectrometry (LC-MS) metabolite analyses in 10 CRC (T) and normal paired tissues (T) along with 10 matched fecal samples (F) and 10 healthy controls (F). The highest microbial phyla abundance from T and T were Firmicutes, while the dominant phyla from F and F were Bacteroidetes, with 72 different microbial genera identified among four groups. No changes in Chao1 indices were detected between tissues or between fecal samples whereas non-metric multidimensional scaling (NMDS) analysis showed distinctive clusters among fecal samples but not tissues. LEfSe analyses indicated Caulobacterales and Brevundimonas were higher in T than in T, while Burkholderialese, Sutterellaceaed, Tannerellaceaea, and Bacteroidaceae were higher in F than in F. Microbial association networks indicated some genera had substantially different correlations. Tissue and fecal analyses indicated lipids and lipid-like molecules were the most abundant metabolites detected in fecal samples. Moreover, partial least squares discriminant analysis (PLS-DA) based on metabolic profiles showed distinct clusters for CRC and normal samples with a total of 102 differential metabolites between T and T groups and 700 metabolites different between F and F groups. However, only Myristic acid was detected amongst all four groups. Highly significant positive correlations were recorded between genus-level microbiome and metabolomics data in tissue and feces. And several metabolites were associated with paired microbes, suggesting a strong microbiota-metabolome coupling, indicating also that part of the CRC metabolomic signature was attributable to microbes. Suggesting utility as potential biomarkers, most such microbiome and metabolites showed directionally consistent changes in CRC patients. Nevertheless, further studies are needed to increase sample sizes towards verifying these findings.

摘要

微生物群及其代谢产物在结直肠癌(CRC)致癌过程中的作用日益受到认可。为了揭示新的CRC生物标志物,我们对10对CRC组织(T)和正常配对组织(T)、10份匹配的粪便样本(F)以及10名健康对照者的粪便样本(F)进行了16S rRNA基因测序和液相色谱-质谱(LC-MS)代谢物分析。来自T和T的微生物门丰度最高的是厚壁菌门,而来自F和F的优势门是拟杆菌门,在四组中鉴定出72个不同的微生物属。在组织之间或粪便样本之间未检测到Chao1指数的变化,而非度量多维尺度分析(NMDS)显示粪便样本之间有明显的聚类,但组织之间没有。线性判别分析效应大小(LEfSe)分析表明,柄杆菌目和短波单胞菌属在T中比在T中更高,而伯克霍尔德菌科、萨特菌科、坦纳菌科和拟杆菌科在F中比在F中更高。微生物关联网络表明一些属具有显著不同的相关性。组织和粪便分析表明,脂质和类脂质分子是在粪便样本中检测到的最丰富的代谢物。此外,基于代谢谱的偏最小二乘判别分析(PLS-DA)显示CRC样本和正常样本有明显的聚类,T和T组之间共有102种差异代谢物,F和F组之间有700种代谢物不同。然而,在所有四组中仅检测到肉豆蔻酸。在组织和粪便中,属水平的微生物组和代谢组学数据之间记录到高度显著的正相关。并且几种代谢物与配对的微生物相关,表明微生物群-代谢组有很强的耦合,这也表明CRC代谢组特征的一部分可归因于微生物。大多数此类微生物组和代谢物在CRC患者中显示出方向一致的变化,表明其作为潜在生物标志物的效用。然而,需要进一步研究以增加样本量来验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/fc4673f61485/fmicb-14-1034325-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/e5c45b249225/fmicb-14-1034325-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/4c8b755c54b7/fmicb-14-1034325-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/13df4ea3161f/fmicb-14-1034325-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/fc4673f61485/fmicb-14-1034325-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/e5c45b249225/fmicb-14-1034325-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/4c8b755c54b7/fmicb-14-1034325-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/13df4ea3161f/fmicb-14-1034325-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f84/9880203/fc4673f61485/fmicb-14-1034325-g004.jpg

相似文献

1
Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer.组织和粪便的微生物群及代谢特征揭示了结直肠癌的诊断生物标志物。
Front Microbiol. 2023 Jan 13;14:1034325. doi: 10.3389/fmicb.2023.1034325. eCollection 2023.
2
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
3
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.整合微生物组和代谢组分析揭示了共生菌和结直肠癌代谢物之间的新相互作用。
Theranostics. 2019 May 31;9(14):4101-4114. doi: 10.7150/thno.35186. eCollection 2019.
4
Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.结直肠癌中肠道微生物群和粪便代谢组的改变:肠道代谢对肿瘤发生的影响
Front Physiol. 2022 May 4;13:854545. doi: 10.3389/fphys.2022.854545. eCollection 2022.
5
Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.粪便代谢组和肠道微生物组之间的关键相互作用揭示了脑缺血性中风的功能特征。
J Transl Med. 2022 Oct 8;20(1):459. doi: 10.1186/s12967-022-03669-0.
6
H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples.基于 1H-NMR 的代谢组学揭示了结直肠肿瘤组织和粪便样本之间重叠的有区别代谢物和代谢途径紊乱。
Int J Cancer. 2019 Sep 15;145(6):1679-1689. doi: 10.1002/ijc.32190. Epub 2019 Mar 4.
7
Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.联合粪便微生物组和代谢组学揭示食管鳞癌的诊断生物标志物。
Microbiol Spectr. 2024 May 2;12(5):e0401223. doi: 10.1128/spectrum.04012-23. Epub 2024 Mar 18.
8
Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.唾液和粪便微生物群:结直肠息肉早期筛查的潜在新生物标志物。
Front Microbiol. 2023 Aug 16;14:1182346. doi: 10.3389/fmicb.2023.1182346. eCollection 2023.
9
Variations in gut microbiota and fecal metabolic phenotype associated with Fenbendazole and Ivermectin Tablets by 16S rRNA gene sequencing and LC/MS-based metabolomics in Amur tiger.基于 16S rRNA 基因测序和 LC/MS 代谢组学分析芬苯达唑和伊维菌素片对东北虎肠道微生物群和粪便代谢表型的影响。
Biochem Biophys Res Commun. 2018 May 15;499(3):447-453. doi: 10.1016/j.bbrc.2018.03.158. Epub 2018 Mar 28.
10
Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites.通过对肠道微生物组和代谢物的特征分析,评估肺部功能受损患者的肺癌风险。
BMC Pulm Med. 2024 Jan 2;24(1):1. doi: 10.1186/s12890-023-02825-6.

引用本文的文献

1
Intratumoral microbial community profiling identifies clinicomolecular and prognostic subtypes of colorectal cancer liver metastasis.瘤内微生物群落分析可识别结直肠癌肝转移的临床分子和预后亚型。
NPJ Precis Oncol. 2025 Aug 15;9(1):284. doi: 10.1038/s41698-025-01075-5.
2
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.从实验室到临床:癌症转移检测与治疗变革中的技术创新
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
3
Metabolic interactions: how gut microbial metabolites influence colorectal cancer.

本文引用的文献

1
Cancer incidence and mortality in China, 2016.2016年中国癌症的发病率和死亡率
J Natl Cancer Cent. 2022 Feb 27;2(1):1-9. doi: 10.1016/j.jncc.2022.02.002. eCollection 2022 Mar.
2
Tumor tissue-specific bacterial biomarker panel for colorectal cancer: Bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicis.用于结直肠癌的肿瘤组织特异性细菌生物标志物组合:马氏拟杆菌、双歧杆菌假链状亚种、卵形拟杆菌onderdonkii、直肠弯曲杆菌。
Arch Microbiol. 2022 May 26;204(6):348. doi: 10.1007/s00203-022-02954-2.
3
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
代谢相互作用:肠道微生物代谢产物如何影响结直肠癌
Front Microbiol. 2025 Jul 23;16:1611698. doi: 10.3389/fmicb.2025.1611698. eCollection 2025.
4
Gut-associated metabolites and diabetes pathology: a systematic review.肠道相关代谢产物与糖尿病病理:一项系统综述
Front Endocrinol (Lausanne). 2025 May 21;16:1559638. doi: 10.3389/fendo.2025.1559638. eCollection 2025.
5
Impact of weight variation on the microbiome of yak dams and calves.体重变化对牦牛母畜和犊牛微生物组的影响。
Front Microbiol. 2024 Sep 18;15:1465992. doi: 10.3389/fmicb.2024.1465992. eCollection 2024.
6
Gut microbiota characteristics of colorectal cancer patients in Hubei, China, and differences with cohorts from other Chinese regions.中国湖北地区结直肠癌患者的肠道微生物群特征及其与中国其他地区队列的差异。
Front Microbiol. 2024 Jun 19;15:1395514. doi: 10.3389/fmicb.2024.1395514. eCollection 2024.
7
Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.鉴定结直肠癌中 KRAS 突变相关的肠道微生物群,并构建预测性机器学习模型。
Microbiol Spectr. 2024 May 2;12(5):e0272023. doi: 10.1128/spectrum.02720-23. Epub 2024 Apr 4.
8
Zhang-LL Inhibits Colitis-Related Tumorigenesis by Regulating Arachidonic Acid Metabolism and CD22-Mediated B-Cell Receptor Regulation.Zhang-LL 通过调节花生四烯酸代谢和 CD22 介导的 B 细胞受体调节抑制结肠炎相关肿瘤发生。
Nutrients. 2023 Oct 25;15(21):4512. doi: 10.3390/nu15214512.
9
Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment.用于结直肠癌治疗的益生菌衍生生物活性化合物
Microorganisms. 2023 Jul 27;11(8):1898. doi: 10.3390/microorganisms11081898.
10
Features of combined gut bacteria and fungi from a Chinese cohort of colorectal cancer, colorectal adenoma, and post-operative patients.中国结直肠癌、结直肠腺瘤及术后患者队列中肠道细菌和真菌组合的特征
Front Microbiol. 2023 Aug 8;14:1236583. doi: 10.3389/fmicb.2023.1236583. eCollection 2023.
肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
4
Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages.不同抗癌治疗阶段的结直肠癌患者的代谢组学比较
Front Oncol. 2022 Feb 4;11:574318. doi: 10.3389/fonc.2021.574318. eCollection 2021.
5
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
6
The gut microbial diversity of colon cancer patients and the clinical significance.结肠癌患者的肠道微生物多样性及其临床意义。
Bioengineered. 2021 Dec;12(1):7046-7060. doi: 10.1080/21655979.2021.1972077.
7
Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence.肠道微生物群与结直肠癌的发生发展:深入探究腺瘤-癌序列
Biomedicines. 2020 Nov 10;8(11):489. doi: 10.3390/biomedicines8110489.
8
Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.使用气相色谱-质谱联用技术进行血清代谢组学分析以筛选食管鳞状细胞癌和食管鳞状上皮发育异常的生物标志物
ACS Omega. 2020 Oct 12;5(41):26402-26412. doi: 10.1021/acsomega.0c02600. eCollection 2020 Oct 20.
9
Growth rate alterations of human colorectal cancer cells by 157 gut bacteria.157 种肠道细菌对人结直肠癌细胞生长速度的影响。
Gut Microbes. 2020 Nov 9;12(1):1-20. doi: 10.1080/19490976.2020.1799733.
10
Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.基于非靶向代谢组学方法探讨与食管鳞癌放化疗敏感性相关的血浆代谢物变化。
BMC Cancer. 2020 Sep 2;20(1):835. doi: 10.1186/s12885-020-07336-9.